Ultrasound Features of Endometriosis of the Uterosacral Ligaments
NCT ID: NCT06787352
Last Updated: 2025-01-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
228 participants
OBSERVATIONAL
2023-02-16
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Association Between Ultrasound Morphology of Intestinal Endometriosis Nodules and Symptom Severity
NCT06720688
Ultrasonographic Characterization of Parametrial Lesions in Deep Endometriosis: A Diagnostic-Accuracy Study (ULTRA-PARAMETRENDO III)
NCT06017531
Intraoperative Intraabdominal Ultrasound for Endometriosis
NCT05812937
Impact of Deep Endometriosis Surgery on Bladder Function
NCT02238678
Pelvic Congestion Syndrome and Endometriosis
NCT03568149
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study group
Endometriosis patients with diseased LUS
No interventions assigned to this group
Control group
Endometriosis patients with healthy LUS
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age between 18 and 50 years;
* Signature of informed consent to the study
Exclusion Criteria
* Virgo patients;
* Hysterectomised patients;
* Pregnant patients;
* Patients undergoing pelvic/vaginal radiotherapy;
* Previous LUS surgery;
* Clinical diagnosis of pelvic organ prolapse;
* Preoperative ultrasound more than 60 days prior to surgery;
* Failure at surgery and any subsequent histopathological examination to find pelvic endometriosis
18 Years
50 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
IRCCS Azienda Ospedaliero-Universitaria di Bologna
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Diego Raimondo, MD
Role: PRINCIPAL_INVESTIGATOR
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Bologna, Italy
Azienda Ospedaliera Universitaria Senese
Siena, Siena, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LUS2022
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.